|
May 27
|
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
|
|
May 26
|
3 Top Growth Stocks to Buy in the Second Half of 2025
|
|
May 24
|
2 Monster Growth Stocks to Buy and Hold for 10 Years
|
|
May 21
|
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
|
|
May 6
|
Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash
|
|
May 6
|
S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop
|
|
May 6
|
Why Did Vertex Pharmaceuticals Stock Fall On Tuesday?
|
|
May 6
|
Uber-Pony AI partnership, EVgo boost, Vertex earnings miss
|
|
May 6
|
Stock Market Today: Dow Jones, S&P 500 Losses Climb; These Two New Issues Jump While Palantir Tanks (Live Coverage)
|
|
May 6
|
Vertex Pharmaceuticals (NasdaqGS:VRTX) Raises Guidance Despite Intangible Asset Impairment Charge
|
|
May 6
|
Vertex Pharmaceuticals Stock Is Tumbling After Earnings. Here’s Why.
|
|
May 6
|
VRTX's Q1 Earnings Lag Estimates, 2025 Revenue View Tightened
|
|
May 6
|
Top Stock Movers Now: Vertex, DoorDash, Constellation Energy, and More
|
|
May 6
|
Vertex Pharmaceuticals Stock Sinks as Costs Soar
|
|
May 6
|
Why Vertex Pharmaceuticals Stock Is Sinking Today
|
|
May 6
|
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks
|
|
May 6
|
Rising Costs Weigh on Vertex Q1 Earnings
|
|
May 6
|
Q1 2025 Vertex Pharmaceuticals Inc Earnings Call
|
|
May 6
|
Vertex Pharmaceuticals Inc (VRTX) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Challenges
|
|
May 5
|
Vertex Pharmaceuticals (VRTX) Misses Q1 Earnings and Revenue Estimates
|